Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
N

NTRA

Nasdaq

Natera, Inc.

Latest disclosureOctober 2, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 273 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 310

Limited filing history
All310Buying0Selling273Other37
Filters

Last 30 daysNo qualifying insider buying. Sales: $63.19M by 4 insiders.

37 of 310 trades · March 31, 2026 – October 1, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 37 trades on this page.

Gift disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Value context
Not a purchase
Reported price
Gift · no purchase price
Understand this price

The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.

Traded September 16, 2026Filed September 18, 2026SEC filing
Award disclosed

John Fesko

PRESIDENT, CHIEF BUS. OFFICER

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 6, 2026Filed August 28, 2026SEC filing
Award disclosed

Eric H. Rubin

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

Herm Rosenman

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

Herm Rosenman

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

Gail Boxer Marcus

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

Gail Boxer Marcus

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

Thomas J. Lynch Jr.

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

Rowan E. Chapman

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

Rowan E. Chapman

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

Roelof Botha

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

Roelof Botha

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

Monica Bertagnolli

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

Monica Bertagnolli

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

Roy D. Baynes

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

Roy D. Baynes

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded June 26, 2026Filed June 30, 2026SEC filing
Exercise or conversion

Gail Boxer Marcus

Director

Common Stock

Value context
$251.13K
Reported price
$22.83 / share
Traded June 5, 2026Filed June 9, 2026SEC filing
Exercise or conversion

Gail Boxer Marcus

Director

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$22.83 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded June 5, 2026Filed June 9, 2026SEC filing
Award disclosed

Eric H. Rubin

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded May 29, 2026Filed June 3, 2026SEC filing
Award disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded May 5, 2026Filed May 6, 2026SEC filing
Award disclosed

Herm Rosenman

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded April 24, 2026Filed April 28, 2026SEC filing
Award disclosed

Herm Rosenman

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded April 24, 2026Filed April 28, 2026SEC filing
Award disclosed

Gail Boxer Marcus

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded April 24, 2026Filed April 28, 2026SEC filing
Award disclosed

Gail Boxer Marcus

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded April 24, 2026Filed April 28, 2026SEC filing
Award disclosed

Rowan E. Chapman

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded April 24, 2026Filed April 28, 2026SEC filing
Award disclosed

Rowan E. Chapman

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded April 24, 2026Filed April 28, 2026SEC filing
Award disclosed

Roelof Botha

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded April 24, 2026Filed April 28, 2026SEC filing
Award disclosed

Roelof Botha

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded April 24, 2026Filed April 28, 2026SEC filing
Award disclosed

Eric H. Rubin

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded April 24, 2026Filed April 28, 2026SEC filing
Award disclosed

Brinkley Ruth Williams

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded April 24, 2026Filed April 28, 2026SEC filing
Award disclosed

Monica Bertagnolli

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded April 24, 2026Filed April 28, 2026SEC filing
Award disclosed

Roy D. Baynes

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded April 24, 2026Filed April 28, 2026SEC filing
Exercise or conversion

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Value context
$559.02K
Reported price
$9.59 / share
Traded April 6, 2026Filed April 8, 2026SEC filing
Tax or exercise withholding

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Value context
$5.66M
Reported price
$204.87 / share
Traded April 6, 2026Filed April 8, 2026SEC filing
Exercise or conversion

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$9.59 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded April 6, 2026Filed April 8, 2026SEC filing
Exercise or conversion

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Value context
$399.98K
Reported price
$9.59 / share
Traded March 31, 2026Filed April 1, 2026SEC filing
Exercise or conversion

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$9.59 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded March 31, 2026Filed April 1, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
PRESIDENT, CLINICALDIAGNOSTICSCommon StockGift945Gift · no purchase priceNot a purchaseSep 16Filed Sep 18 · 2d laterSEC filing
PRESIDENT, CHIEF BUS. OFFICERCommon StockGrant or award10b5-120,000Award · no purchase priceNon-cash awardAug 6Filed Aug 28 · 22d laterSEC filing
DirectorCommon StockGrant or award75Price not reportedUnavailableJun 26Filed Jun 30 · 4d laterSEC filing
DirectorCommon StockGrant or award1,571Price not reportedUnavailableJun 26Filed Jun 30 · 4d laterSEC filing
DirectorCommon StockGrant or award106Price not reportedUnavailableJun 26Filed Jun 30 · 4d laterSEC filing
DirectorCommon StockGrant or award1,571Price not reportedUnavailableJun 26Filed Jun 30 · 4d laterSEC filing
DirectorCommon StockGrant or award98Price not reportedUnavailableJun 26Filed Jun 30 · 4d laterSEC filing
DirectorCommon StockGrant or award1,905Price not reportedUnavailableJun 26Filed Jun 30 · 4d laterSEC filing
DirectorCommon StockGrant or award1,571Price not reportedUnavailableJun 26Filed Jun 30 · 4d laterSEC filing
DirectorCommon StockGrant or award103Price not reportedUnavailableJun 26Filed Jun 30 · 4d laterSEC filing
DirectorCommon StockGrant or award1,571Price not reportedUnavailableJun 26Filed Jun 30 · 4d laterSEC filing
DirectorCommon StockGrant or award120Price not reportedUnavailableJun 26Filed Jun 30 · 4d laterSEC filing
DirectorCommon StockGrant or award1,571Price not reportedUnavailableJun 26Filed Jun 30 · 4d laterSEC filing
DirectorCommon StockGrant or award75Price not reportedUnavailableJun 26Filed Jun 30 · 4d laterSEC filing
DirectorCommon StockGrant or award1,571Price not reportedUnavailableJun 26Filed Jun 30 · 4d laterSEC filing
DirectorCommon StockGrant or award75Price not reportedUnavailableJun 26Filed Jun 30 · 4d laterSEC filing
DirectorCommon StockOption exercise or conversion11,000$22.83 / share$251.13KJun 5Filed Jun 9 · 4d laterSEC filing
DirectorStock Option (right to buy)Option exercise or conversionDerivative units11,000$22.83 exercise / conversion priceNot a separate purchaseJun 5Filed Jun 9 · 4d laterSEC filing
DirectorCommon StockGrant or award2,124Price not reportedUnavailableMay 29Filed Jun 3 · 5d laterSEC filing
EXECUTIVE CHAIRMANCommon StockGrant or award10b5-12,389Price not reportedUnavailableMay 5Filed May 6 · 1d laterSEC filing
DirectorCommon StockGrant or award117Price not reportedUnavailableApr 24Filed Apr 28 · 4d laterSEC filing
DirectorCommon StockGrant or award222Price not reportedUnavailableApr 24Filed Apr 28 · 4d laterSEC filing
DirectorCommon StockGrant or award108Price not reportedUnavailableApr 24Filed Apr 28 · 4d laterSEC filing
DirectorCommon StockGrant or award222Price not reportedUnavailableApr 24Filed Apr 28 · 4d laterSEC filing
DirectorCommon StockGrant or award114Price not reportedUnavailableApr 24Filed Apr 28 · 4d laterSEC filing
DirectorCommon StockGrant or award222Price not reportedUnavailableApr 24Filed Apr 28 · 4d laterSEC filing
DirectorCommon StockGrant or award132Price not reportedUnavailableApr 24Filed Apr 28 · 4d laterSEC filing
DirectorCommon StockGrant or award222Price not reportedUnavailableApr 24Filed Apr 28 · 4d laterSEC filing
DirectorCommon StockGrant or award5Price not reportedUnavailableApr 24Filed Apr 28 · 4d laterSEC filing
DirectorCommon StockGrant or award86Price not reportedUnavailableApr 24Filed Apr 28 · 4d laterSEC filing
DirectorCommon StockGrant or award83Price not reportedUnavailableApr 24Filed Apr 28 · 4d laterSEC filing
DirectorCommon StockGrant or award83Price not reportedUnavailableApr 24Filed Apr 28 · 4d laterSEC filing
EXECUTIVE CHAIRMANCommon StockOption exercise or conversion58,292$9.59 / share$559.02KApr 6Filed Apr 8 · 2d laterSEC filing
EXECUTIVE CHAIRMANCommon StockExercise-price or tax withholding27,610$204.87 / share$5.66MApr 6Filed Apr 8 · 2d laterSEC filing
EXECUTIVE CHAIRMANStock Option (right to buy)Option exercise or conversionDerivative units58,292$9.59 exercise / conversion priceNot a separate purchaseApr 6Filed Apr 8 · 2d laterSEC filing
EXECUTIVE CHAIRMANCommon StockOption exercise or conversion41,708$9.59 / share$399.98KMar 31Filed Apr 1 · 1d laterSEC filing
EXECUTIVE CHAIRMANStock Option (right to buy)Option exercise or conversionDerivative units41,708$9.59 exercise / conversion priceNot a separate purchaseMar 31Filed Apr 1 · 1d laterSEC filing

Congress transactions 1

All Congress filings
Purchase disclosed

Natera, Inc. - Common Stock (NTRA) · Stock

The filing reports a purchase for a joint account.

Josh Gottheimer official portraitJosh GottheimerReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
September 22, 2025
Filed October 15, 2025 · 23d laterOriginal report
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001604821
Latest public acceptance
Oct 3, 2026, 01:35 AM UTC
Score calculated
Oct 8, 2026, 12:08 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.